|
|
Article: Epigenetics Gains Momentum; Novartis Teams up with Orion.
- Article from:
- BIOWORLD Today
- Article date:
- October 12, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Orion Genomics LLC is expected to announce on Monday a collaboration with Novartis AG aimed at discovering epigenetic biomarkers for use in diagnostics.
Terms for the deal were not disclosed, although St. Louis-based Orion and Basel, Switzerland-based Novartis each will retain rights to commercialize certain resulting diagnostics.
Epigenetics refers to how gene expression is influenced by structural modifications, such as DNA methylation or histone acetylation, that change the way a DNA sequence is packaged without changing the sequence itself. The classic example is stem cells, which divide and differentiate to become every cell ...